Olink

Olink®
Part of Thermo Fisher Scientific

Immune related proteins and tumor infiltrating <scp>CD8</scp>+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (<scp>HPV</scp>) and clinical outcome

Head & Neck, 2020

Landin D., Ährlund‐Richter A., Mirzaie L., Mints M., Näsman A., Kolev A., Marklund L., Dalianis T., Munck‐Wikland E., Ramqvist T.

Disease areaApplication areaSample typeProducts
Oncology
Pathophysiology
Tissue Lysate
Olink Target 96

Olink Target 96

Abstract

Background

Hypopharyngeal cancer (HPSCC) shows a poor clinical outcome, while HPSCC, caused by human papillomavirus (HPV), presents a better outcome. Here, HPCC, immune proteins, and tumor infiltrating CD8+ lymphocytes (CD8+ TILs) were evaluated in relation to HPV and outcome.

Methods

Fresh frozen tissue from four HPV‐positive HPSCC, 39 HPV‐negative HPSCC, and normal samples were analyzed for protein expression by the Proseek immuno‐oncology immunoassay. CD8+ TIL numbers evaluated by immunohistochemistry on 144 formalin‐fixed biopsies were analyzed in relation to clinical outcome.

Results

Proteins differing between HPV‐positive and negative HPSCC included CD8A, PD‐L1, Fas ligand, and chemokines. High CD8+ TIL numbers were correlated to improve clinical outcome in HPV‐negative HPSCC.

Conclusions

High expression of immune proteins in HPV‐positive HPSCC may explain the better clinical outcome. CD8+ TILs are of relevance for outcome of HPV‐negative HPSCC, while tumors with high immune activity but poor patient survival suggest a role for immune therapy.

Read publication ↗